GlassScriptPhysician profile
Emma L Clay
NPI 1053387365
$1,888.06
in general payments reported to CMS, 2019-2025
18 companies · $1,174 in 2025
The $1,174 reported for 2025 was more than what 81% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $137 · 2021: $83.29 · 2022: $93.20 · 2024: $260 · 2025: $1,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856 · Consulting Fee: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.42 |
| Consulting Fee | $577.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $660.93 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Sun Pharmaceutical Industries INC. | $236.90 | 2021-2025 | |
| New World Medical,INC. | $221.88 | 2020-2024 | Streamline, Clearpath, Kahook Dual Blade |
| Harrow Eye, LLC | $131.99 | 2025 | Vevye |
| Johnson & Johnson Surgical Vision, INC. | $104.72 | 2019 | |
| Abbvie INC. | $102.66 | 2022-2024 | |
| Dompe US, INC. | $76.90 | 2021-2025 | Oxervate |
| Allergan, INC. | $58.48 | 2020-2021 | |
| Thea Pharma INC. | $46.56 | 2024-2025 | Iyuzeh |
| Merz Pharmaceuticals, LLC | $46.30 | 2025 | Xeomin |
| Alcon Vision LLC | $43.12 | 2022-2025 | Rocklatan |
| Aerie Pharmaceuticals, INC. | $42.06 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $34.85 | 2020-2021 | |
| Tarsus Pharmaceuticals, INC. | $25.12 | 2025 | Xdemvy |
| Shire North American Group INC | $23.58 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Biotissue Holdings INC. | $12.61 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Clay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.